Freedom to Grow: Why an Open, Interoperable Platform Is Non-Negotiable for Digital Pathology

As laboratories scale digital pathology, interoperability gives them the freedom to add sites, connect systems, adopt new AI applications, and pursue growth without rebuilding their workflows. Ashley Faber explores why true openness must extend beyond a vendor’s claims and how Concentriq supports flexibility through integrations designed around pathologists’ day-to-day work, a commitment to DICOM, a broad precision medicine AI portfolio, and the Predetermined Change Control Plan authorized in Proscia’s latest FDA clearance for Concentriq AP-Dx.